Can vitamin D supplementation reduce prostate cancer disparities? (Q46658342)

24 December 2017

http://europepmc.org/abstract/MED/27380910

editorial

0 references

review article

1 reference

title

Can vitamin D supplementation reduce prostate cancer disparities? (English)

1 reference

24 December 2017

http://europepmc.org/abstract/MED/27380910

0 references

Ken Batai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

Rick A Kittles

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

publication date

6 July 2016

1 reference

24 December 2017

http://europepmc.org/abstract/MED/27380910

published in

Pharmacogenomics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

page(s)

1117-1120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

cites work

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

The role of vitamin D in reducing cancer risk and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Serum vitamin D concentration and prostate cancer risk: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Vitamin D deficiency predicts prostate biopsy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Genes associated with prostate cancer are differentially expressed in African American and European American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS-2016-0089

Randomized Clinical Trial of Vitamin D3 Doses on Prostatic Vitamin D Metabolite Levels and Ki67 Labeling in Prostate Cancer Patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27380910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27380910

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2217/PGS-2016-0089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6562891&resulttype=core&format=json